Abstract:In our previous work, 5-hexyloxy-[1. 2. 4] triazolo [4.3-a] quinoline (compound Ⅰ) showed potent anticonvulsant activity, with ED50 value of 19.0 mg•kg^(-1) and protective index (PI=TD50/ED50) values of 5.8 in the MES test. As part of our continuous effort to find better anticonvulsant candidate in this area, twelve derivatives of leading compound Ⅰ were synthesized by the modification of 1,2, and 5 positions of it. In addition, their anticonvulsant activity and neurotoxicity were evaluated using the MES test and the rotarod test in mice, respectively. In the same condition, the 50% toxic dose (TD50) and 50% effective dose (ED50) of the reference drugs carbamazepine and the leading compound Ⅰ were evaluated in MES test and the rotarod test in our laboratory. The results of pharmacological tests demonstrated that some target compounds (6a, 10a, 10b) displayed anticonvulsant activities in different doses, and 5-hexyloxy-1-methyl-[1, 2, 4] triazolo [4, 3-a] quinoline (10b) showed good activity with an ED50 value of 18.0 mg•kg^(-1) and protective index (PI=TD50/ED50) value of 7.9. The anticonvulsant activity (ED50 and PI) of 10b is better than that of the leading compound Ⅰ. Compared to the reference drugs, compound 10b exhibited the weaker activity, while it possessed the higher PI value. which mean that compound 10b is safer than marketed drug carbamazepine.

The Synthesis and Anticonvulsant Activity of 1-Substituted-7-methoxy-1,2,4-triazolo [4,~3-A]quinoline

The Synthesis and Anticonvulsant Activity of 1-Substituted-7-methoxy-1,2,4-triazolo [4, 3-A] Quinoline

Synthesis And Anticonvulsant Activity Study Of 7-Substituted Phenoxyl-4,5-Dihydro[1,2,4]Triazolo[4,3-A]Quinolines And Quinoline-1(2h)-Ones

Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4h)-one and Its Derivatives

Synthesis and anticonvulsant activity evaluation of 8-alkoxy-5-(4 H -1,2,4-triazol-4-yl)quinoline derivatives

Synthesis of 2-Substituted-7-heptyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-1(2 H)-Ones with Anticonvulsant Activity

Synthesis and Anticonvulsant Activity of 5-Substituted-[1,2,4]triazolo[4,3-a]quinazolines

Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline.

Synthesis and Anticonvulsant Evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4h-1,2,4-triazoles As Open-Chain Analogues of 7-Alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolines.

Synthesis and Anticonvulsant Evaluation of 3-Substituted-4-(4-hexyloxyphenyl)-4h-1,2,4-triazoles

Synthesis and anticonvulsant activity of 7-benzylamino-4, 5dihydro-[1,2,4] triazolo[4,3-a]quinolines

Synthesis and Anticonvulsant Activity Evaluation of 4‐Phenyl‐[1,2,4]triazolo[4,3‐a]quinazolin‐5(4H)‐one and Its Derivatives

Synthesis and Anticonvulsant Activities of 4-Alkoxyl-[1,2,4]Triazolo[4,3-a]Quinoxaline Derivatives

Synthesis and Anticonvulsant Activity of 5‐Phenyl‐[1,2,4]‐triazolo[4,3‐a]quinolines

Design, Synthesis of 8-Alkoxy-5,6-dihydro-[1,2,4]triazino[4,3-a]quinolin-1-ones with Anticonvulsant Activity

Synthesis and Evaluation of the Anticonvulsant Activity of 5-Alkylthio-4- Phenyl-2,4-dihydro-3h-1,2,4-triazol-3-one Derivatives

Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.

Design, Synthesis and Anticonvulsant Activity Evaluation of Novel 4-(4-Substitutedphenyl)-3-methyl-1h-1,2,4-triazol-5(4h)-ones.

Synthesis and Anticonsulvant Activity of 1,2,4-Triazolo[4,3-a] Quinolines

Synthesis and Anticonvulsant Activity of 7-Alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines

Synthesis and Analysis of Anticonvulsant Activities of New 4-[ 2-( 4alkoxybenzylamino) Ethyl]-2h-1,2,4-Triazol-3( 4H)- One Derivatives